featured
2022 Top Story in Brain Cancer: GD2-CAR T-Cell Therapy for H3K27M-Mutated Diffuse Midline Gliomas
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.